Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2022 Feb 24;17(1):15.
doi: 10.5334/gh.1106. eCollection 2022.

Transcatheter Closure of Perimembranous Ventricular Septal Defect Using the Lifetech Konar-Multi Functional Occluder: Early to Midterm Results of the Indonesian Multicenter Study

Rahmat Budi Kuswiyanto  1 , Eka Gunawijaya  2 , Mulyadi M Djer  3 , Noormanto  4 , Mahrus A Rahman  5 , Indah K Murni  4 , Rubiana Sukardi  6 , Alit Utamayasa  5 , Rizky Ardiansyah  7 , Ria Nova  8 , Sri Liliyanti  9 , Sri E Rahayuningsih  1 , Shirley L Anggriawan  10 , Tri Yanti Rahayuningsih  11 , Dyahris Koentartiwi  12 , Renny Soewarniaty  12 , Venny Kartika Yantie  2 , Sasmito Nugroho  4 , Taufiq Hidayat  5 , Teddy Ontoseno  5 , Tina C Tobing  7 , Muhamad Ali  7 , Muhammad Hasan Bashari  13 , Denny S Yosy  8 , Nadya Arafuri  4 , Dany Hilmanto  1 , Piprim B Yanuarso  3 , Najib Advani  3 , Sudigdo Sastroasmoro  3 , Sukman Tulus Putra  3
Affiliations
Multicenter Study

Transcatheter Closure of Perimembranous Ventricular Septal Defect Using the Lifetech Konar-Multi Functional Occluder: Early to Midterm Results of the Indonesian Multicenter Study

Rahmat Budi Kuswiyanto et al. Glob Heart. .

Abstract

Background: The alternative device to close perimembranous ventricular septal defect (pmVSD) has been searched for better result, less complications and applicable for infants. However, the ideal device is still unavailable. We aimed to evaluate the effectiveness and outcome of transcatheter pmVSD closure using the KONAR-multi functional occluder (MFO).

Methods: Clinical, procedural, follow-up data of pmVSD patients with symptom of heart failure or evidence of significant left to right shunt, growth failure, recurrent respiratory tract infection, and history of endocarditis who underwent transcatheter closure using the MFO were prospectively evaluated.

Results: Between January 2016 and December 2017, there were complete records of 132 pmVSD children closed using MFO from eleven centers in Indonesia. The median of age was 4.5 (0.3-17.4) years; weight 14.8 (3.5-57) kg, defect size at the smallest part 3.4 (1.0-8.1) mm, flow ratio 1.6 (1.3-4.9), mean pulmonary artery pressure 18 (7-79) mmHg, fluoroscopy time 18 (3.8-91) and procedural time 75 (26-290) minutes. A retrograde approach was done in 41 (31%) patients. Procedures succeeded in first attempt in 126 (95.4%), failed in three and migration in three patients. Six of eight infants with congestive heart failure were closed successfully. Of 126 patients with successful VSD closure, 12 months follow-up were completed in all patients. The rate of complete occlusion at 1 month, 3 months, 6 months and 12 months after intervention were 95.2%, 97.6%, 99.2%, and 99.2%, respectively. New-onset aortic regurgitation and moderate tricuspid regurgitation developed only in five and three patients. Neither complete atrioventricular block, nor other complications occurred.

Conclusion: Transcatheter closure of pmVSD using the MFO is safe, effective, and feasible in infants and children.

Keywords: KONAR-multi functional occluder; Perimembranous ventricular septal defect; transcatheter closure.

PubMed Disclaimer

Conflict of interest statement

The authors have no competing interests to declare.

Figures

The KONAR-Multi Functional Occluder. Device components denomination: D. Disc diameter; D1. Waist Diameter Right Ventricular side; D2. Waist Diameter Left Ventricular side.
Image/Figure 1
The KONAR-Multi Functional Occluder. Device components denomination: D. Disc diameter; D1. Waist Diameter Right Ventricular side; D2. Waist Diameter Left Ventricular side.
Angiography and echocardiography after closure.
Image/Figure 2
Angiography and echocardiography after closure.
Flow chart of transcatheter in ventricular septal defect closure of a multicenter study in Indonesia.
Image/Figure 3
Flow chart of transcatheter in ventricular septal defect closure of a multicenter study in Indonesia.
See this image and copyright information in PMC

References

    1. Hijazi ZM, Hakim F, Haweleh AA, et al. Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: Initial clinical experience. Catheter Cardiovasc Interv. 2002; 56: 508–15. DOI: 10.1002/ccd.10292 - DOI - PubMed
    1. Bass JL, Kalra GS, Arora R, et al. Initial human experience with the Amplatzer perimembranous ventricular septal occluder device. Catheter Cardiovasc Interv. 2003; 58: 238–45. DOI: 10.1002/ccd.10406 - DOI - PubMed
    1. Fu YC, Bass J, Amin Z, et al. Transcatheter closure of perimembranous VSD using new Amplatzer Membranous VSD Occluder. J Am Coll Cardiol. 2006; 47: 319–25. DOI: 10.1016/j.jacc.2005.09.028 - DOI - PubMed
    1. Holzer R, de Giovanni J, Walsh KP, et al. Transcatheter closure of perimembranous ventricular septal defects using the Amplatzer membranous VSD occluder: Immediate and midterm results of an international registry. Catheter Cardiovasc Interv. 2006; 68: 620–28. DOI: 10.1002/ccd.20659 - DOI - PubMed
    1. Carminati M, Butera G, Chessa M, et al. Transcatheter closure of congenital ventricular septal defects: Results of the European Registry. Eur Heart J. 2007; 28: 2361–8. DOI: 10.1093/eurheartj/ehm314 - DOI - PubMed

Publication types